EGBN
Eagle Bancorp, Inc.
EGBN's fundamentals are strong, but it looks expensive: trading at 24x earnings, more than twice its usual 9.4x. Analysts expect strong earnings growth, though they disagree widely on how much.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
EGBN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
EGBN's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like EGBN.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
EGBN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.8x | $9.58 | -72% |
| Fair | 9.3x | $13.05 | -62% |
| Expensive | 11x | $15.45 | -55% |
| Forward | 15x | $34.38 | — |
| Current | 24x | $34.38 | — |
Historical ranges are pointers, not guarantees.
EGBN's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
EGBN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect EGBN's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
EGBN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.28 | +62% |
| Q3 2026 | $1.41 | +$5.36 |
| Q2 2026 | -$1.60 | -$0.59 |
| Q1 2026 | -$4.13 | -$2.64 |
| Q4 2025 | -$4.55 | -$2.99 |
| Q3 2025 | -$3.95 | -$2.56 |
| Q2 2025 | -$1.01 | +$0.19 |
| Q1 2025 | -$1.49 | -159% |
| Q4 2024 | -$1.56 | -147% |
EGBN has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
EGBN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $70.9M | +0.3% |
| Q2 2026 | $73.1M | -1.5% |
| Q1 2026 | $76.4M | +3.4% |
| Q4 2025 | $80.5M | +7.5% |
| Q3 2025 | $70.7M | -10% |
| Q2 2025 | $74.2M | -3.3% |
| Q1 2025 | $73.9M | -5.7% |
| Q4 2024 | $74.9M | -1.4% |
EGBN's revenue fell from its 2020 peak and has held roughly level since: $71M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | +149 points |
| Q2 2026 | 10% | +158 points |
| Q1 2026 | 21% | +18 points |
| Q4 2025 | -6.2% | -33 points |
| Q3 2025 | -119% | -153 points |
| Q2 2025 | -147% | -44 points |
| Q1 2025 | 3.3% | -0.1 points |
| Q4 2024 | 26% | -6.4 points |
EGBN has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over EGBN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
EGBN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $54.2M | +242% |
| Q2 2026 | $31.5M | +$60.9M |
| Q1 2026 | $14.3M | -67% |
| Q3 2025 | $15.8M | -72% |
| Q2 2025 | -$29.3M | -153% |
| Q1 2025 | $43M | +1413% |
| Q3 2024 | $55.6M | +17% |
| Q2 2024 | $55.2M | +80% |
EGBN's free cash flow was $91M over the past year, up 7.2% from the year before. Free cash flow isn't a meaningful measure for financial services companies like EGBN.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
EGBN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +64K shares |
| 1 year | +0.9% | +266K shares |
| 3 years | +2.3% | +690K shares |
| 5 years | -4.4% | -1.4M shares |
| Available history | -10% | -3.6M shares |
EGBN has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | $2,000 |
| Q3 2023 | $2,000 |
| Q2 2023 | $29.7M |
| Q1 2023 | $18.4M |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
EGBN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q1 2024 | 16.2x | High |
| Q4 2023 | 0.7x | Very low |
| Q3 2023 | 0.4x | Very low |
| Q2 2023 | 0.4x | Very low |
| Q1 2023 | 0.4x | Very low |
| Q4 2022 | 5.5x | High |
| Q3 2022 | 0.2x | Very low |
EGBN's net debt is about 1.5 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like EGBN.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
EGBN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.5 | Overbought |
| Stochastic | 89.0 | Overbought |
EGBN's weekly RSI is 73 (overbought) and its Stochastic is 89 (overbought).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
EGBN PE vs Financial Services Sector
| Metric | EGBN | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 13x | 87% above |
| PE % | 100 | 63 | 37 pts above |
EGBN is trading at 24x earnings, a 87% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
EGBN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.1 | 11% above |
| 20 week MA | $29.2 | 18% above |
| 50 week MA | $26.8 | 28% above |
| 100 week MA | $23.5 | 46% above |
| 200 week MA | $24.5 | 40% above |
EGBN has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
EGBN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.8 | $41.0 | -16% |
| 2021 | $41.0 | $56.8 | +39% |
| 2022 | $56.8 | $44.6 | -21% |
| 2023 | $44.6 | $30.1 | -32% |
| 2024 | $30.1 | $26.0 | -14% |
| 2025 | $26.0 | $21.2 | -19% |
| 2026 YTD | $21.2 | $34.4 | +62% |
EGBN has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.